NCT01823289View on ClinicalTrials.gov

An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Pulmonary Fungal Infection
Interventions
DRUG

Itraconazole

Itraconazole 200 milligram (mg) intravenous injection will be given twice daily for first 2 days, 200 mg once daily for the subsequent 12 days, then sequential itraconazole oral solution 200 mg twice daily will be given for 2 to 4 weeks.

All Listed Sponsors
lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT01823289 - An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections | Biotech Hunter | Biotech Hunter